Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with a generic error message. This indicates an access or server problem affecting the visibility of the study record.SummaryDifference18%

- Check19 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0 on the study page, indicating a backend/content update. The update does not modify the study data, eligibility criteria, outcomes, or locations.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page’s revision label changed from v3.6.5 to v3.6.6, representing a minor update to the page’s documentation/version. No substantive content changes to the study details are indicated.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded a funding source entry: 2017 ( U.S. NIH Grant/Contract ). This indicates NIH funding associated with the study.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the study page. There are no indicated changes to the study details in this update.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, reflecting a minor page update. No study content or data has changed.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.